Global Tissue-Based Diagnostics Market Size, Status and Forecast 2020-2026

August 2020 | 96 pages | ID: G6F0BACF878BEN
QYResearch

Abstracts

Tissue-Based Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tissue-Based Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study

• Roche
• Danaher
• Thermo Fisher Scientific
• Abbott
• Agilent Technologies
• ABCAM
• Merck
• BD
• Hologic
• Bio Rad

Market segment by Type, the product can be split into

• Immunohistochemistry (IHC)
• In Situ Hybridization (ISH)
• Digital Pathology and Workflow Management
• Special Staining

Market segment by Application, split into

• Hospitals
• Research Laboratories
• Pharmaceutical Companies
• Contract Research Organizations
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Tissue-Based Diagnostics Revenue
1.4 Market by Type
  1.4.1 Global Tissue-Based Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Immunohistochemistry (IHC)
  1.4.3 In Situ Hybridization (ISH)
  1.4.4 Digital Pathology and Workflow Management
  1.4.5 Special Staining
1.5 Market by Application
  1.5.1 Global Tissue-Based Diagnostics Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Research Laboratories
  1.5.4 Pharmaceutical Companies
  1.5.5 Contract Research Organizations
  1.5.6 Other
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Tissue-Based Diagnostics Market Perspective (2015-2026)
2.2 Global Tissue-Based Diagnostics Growth Trends by Regions
  2.2.1 Tissue-Based Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Tissue-Based Diagnostics Historic Market Share by Regions (2015-2020)
  2.2.3 Tissue-Based Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Tissue-Based Diagnostics Market Growth Strategy
  2.3.6 Primary Interviews with Key Tissue-Based Diagnostics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Tissue-Based Diagnostics Players by Market Size
  3.1.1 Global Top Tissue-Based Diagnostics Players by Revenue (2015-2020)
  3.1.2 Global Tissue-Based Diagnostics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Tissue-Based Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Tissue-Based Diagnostics Market Concentration Ratio
  3.2.1 Global Tissue-Based Diagnostics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Tissue-Based Diagnostics Revenue in 2019
3.3 Tissue-Based Diagnostics Key Players Head office and Area Served
3.4 Key Players Tissue-Based Diagnostics Product Solution and Service
3.5 Date of Enter into Tissue-Based Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE (2015-2026)

4.1 Global Tissue-Based Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Tissue-Based Diagnostics Forecasted Market Size by Type (2021-2026)

5 MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global Tissue-Based Diagnostics Market Size by Application (2015-2020)
5.2 Global Tissue-Based Diagnostics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Tissue-Based Diagnostics Market Size (2015-2020)
6.2 Tissue-Based Diagnostics Key Players in North America (2019-2020)
6.3 North America Tissue-Based Diagnostics Market Size by Type (2015-2020)
6.4 North America Tissue-Based Diagnostics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Tissue-Based Diagnostics Market Size (2015-2020)
7.2 Tissue-Based Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Tissue-Based Diagnostics Market Size by Type (2015-2020)
7.4 Europe Tissue-Based Diagnostics Market Size by Application (2015-2020)

8 CHINA

8.1 China Tissue-Based Diagnostics Market Size (2015-2020)
8.2 Tissue-Based Diagnostics Key Players in China (2019-2020)
8.3 China Tissue-Based Diagnostics Market Size by Type (2015-2020)
8.4 China Tissue-Based Diagnostics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Tissue-Based Diagnostics Market Size (2015-2020)
9.2 Tissue-Based Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Tissue-Based Diagnostics Market Size by Type (2015-2020)
9.4 Japan Tissue-Based Diagnostics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Tissue-Based Diagnostics Market Size (2015-2020)
10.2 Tissue-Based Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Tissue-Based Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Tissue-Based Diagnostics Market Size by Application (2015-2020)

11 INDIA

11.1 India Tissue-Based Diagnostics Market Size (2015-2020)
11.2 Tissue-Based Diagnostics Key Players in India (2019-2020)
11.3 India Tissue-Based Diagnostics Market Size by Type (2015-2020)
11.4 India Tissue-Based Diagnostics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Tissue-Based Diagnostics Market Size (2015-2020)
12.2 Tissue-Based Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Tissue-Based Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Tissue-Based Diagnostics Market Size by Application (2015-2020)

13KEY PLAYERS PROFILES

13.1 Roche
  13.1.1 Roche Company Details
  13.1.2 Roche Business Overview
  13.1.3 Roche Tissue-Based Diagnostics Introduction
  13.1.4 Roche Revenue in Tissue-Based Diagnostics Business (2015-2020))
  13.1.5 Roche Recent Development
13.2 Danaher
  13.2.1 Danaher Company Details
  13.2.2 Danaher Business Overview
  13.2.3 Danaher Tissue-Based Diagnostics Introduction
  13.2.4 Danaher Revenue in Tissue-Based Diagnostics Business (2015-2020)
  13.2.5 Danaher Recent Development
13.3 Thermo Fisher Scientific
  13.3.1 Thermo Fisher Scientific Company Details
  13.3.2 Thermo Fisher Scientific Business Overview
  13.3.3 Thermo Fisher Scientific Tissue-Based Diagnostics Introduction
  13.3.4 Thermo Fisher Scientific Revenue in Tissue-Based Diagnostics Business (2015-2020)
  13.3.5 Thermo Fisher Scientific Recent Development
13.4 Abbott
  13.4.1 Abbott Company Details
  13.4.2 Abbott Business Overview
  13.4.3 Abbott Tissue-Based Diagnostics Introduction
  13.4.4 Abbott Revenue in Tissue-Based Diagnostics Business (2015-2020)
  13.4.5 Abbott Recent Development
13.5 Agilent Technologies
  13.5.1 Agilent Technologies Company Details
  13.5.2 Agilent Technologies Business Overview
  13.5.3 Agilent Technologies Tissue-Based Diagnostics Introduction
  13.5.4 Agilent Technologies Revenue in Tissue-Based Diagnostics Business (2015-2020)
  13.5.5 Agilent Technologies Recent Development
13.6 ABCAM
  13.6.1 ABCAM Company Details
  13.6.2 ABCAM Business Overview
  13.6.3 ABCAM Tissue-Based Diagnostics Introduction
  13.6.4 ABCAM Revenue in Tissue-Based Diagnostics Business (2015-2020)
  13.6.5 ABCAM Recent Development
13.7 Merck
  13.7.1 Merck Company Details
  13.7.2 Merck Business Overview
  13.7.3 Merck Tissue-Based Diagnostics Introduction
  13.7.4 Merck Revenue in Tissue-Based Diagnostics Business (2015-2020)
  13.7.5 Merck Recent Development
13.8 BD
  13.8.1 BD Company Details
  13.8.2 BD Business Overview
  13.8.3 BD Tissue-Based Diagnostics Introduction
  13.8.4 BD Revenue in Tissue-Based Diagnostics Business (2015-2020)
  13.8.5 BD Recent Development
13.9 Hologic
  13.9.1 Hologic Company Details
  13.9.2 Hologic Business Overview
  13.9.3 Hologic Tissue-Based Diagnostics Introduction
  13.9.4 Hologic Revenue in Tissue-Based Diagnostics Business (2015-2020)
  13.9.5 Hologic Recent Development
13.10 Bio Rad
  13.10.1 Bio Rad Company Details
  13.10.2 Bio Rad Business Overview
  13.10.3 Bio Rad Tissue-Based Diagnostics Introduction
  13.10.4 Bio Rad Revenue in Tissue-Based Diagnostics Business (2015-2020)
  13.10.5 Bio Rad Recent Development

14ANALYST'S VIEWPOINTS/CONCLUSIONS

15APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Tissue-Based Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by Tissue-Based Diagnostics Revenue
Table 3. Ranking of Global Top Tissue-Based Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Tissue-Based Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Immunohistochemistry (IHC)
Table 6. Key Players of In Situ Hybridization (ISH)
Table 7. Key Players of Digital Pathology and Workflow Management
Table 8. Key Players of Special Staining
Table 9. Global Tissue-Based Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Tissue-Based Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Tissue-Based Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Tissue-Based Diagnostics Market Share by Regions (2015-2020)
Table 13. Global Tissue-Based Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Tissue-Based Diagnostics Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Tissue-Based Diagnostics Market Growth Strategy
Table 19. Main Points Interviewed from Key Tissue-Based Diagnostics Players
Table 20. Global Tissue-Based Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 21. Global Tissue-Based Diagnostics Market Share by Players (2015-2020)
Table 22. Global Top Tissue-Based Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tissue-Based Diagnostics as of 2019)
Table 23. Global Tissue-Based Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Tissue-Based Diagnostics Product Solution and Service
Table 26. Date of Enter into Tissue-Based Diagnostics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Tissue-Based Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 29. Global Tissue-Based Diagnostics Market Size Share by Type (2015-2020)
Table 30. Global Tissue-Based Diagnostics Revenue Market Share by Type (2021-2026)
Table 31. Global Tissue-Based Diagnostics Market Size Share by Application (2015-2020)
Table 32. Global Tissue-Based Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 33. Global Tissue-Based Diagnostics Market Size Share by Application (2021-2026)
Table 34. North America Key Players Tissue-Based Diagnostics Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Tissue-Based Diagnostics Market Share (2019-2020)
Table 36. North America Tissue-Based Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 37. North America Tissue-Based Diagnostics Market Share by Type (2015-2020)
Table 38. North America Tissue-Based Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 39. North America Tissue-Based Diagnostics Market Share by Application (2015-2020)
Table 40. Europe Key Players Tissue-Based Diagnostics Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Tissue-Based Diagnostics Market Share (2019-2020)
Table 42. Europe Tissue-Based Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Tissue-Based Diagnostics Market Share by Type (2015-2020)
Table 44. Europe Tissue-Based Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Tissue-Based Diagnostics Market Share by Application (2015-2020)
Table 46. China Key Players Tissue-Based Diagnostics Revenue (2019-2020) (Million US$)
Table 47. China Key Players Tissue-Based Diagnostics Market Share (2019-2020)
Table 48. China Tissue-Based Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 49. China Tissue-Based Diagnostics Market Share by Type (2015-2020)
Table 50. China Tissue-Based Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 51. China Tissue-Based Diagnostics Market Share by Application (2015-2020)
Table 52. Japan Key Players Tissue-Based Diagnostics Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Tissue-Based Diagnostics Market Share (2019-2020)
Table 54. Japan Tissue-Based Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Tissue-Based Diagnostics Market Share by Type (2015-2020)
Table 56. Japan Tissue-Based Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Tissue-Based Diagnostics Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Tissue-Based Diagnostics Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Tissue-Based Diagnostics Market Share (2019-2020)
Table 60. Southeast Asia Tissue-Based Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Tissue-Based Diagnostics Market Share by Type (2015-2020)
Table 62. Southeast Asia Tissue-Based Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Tissue-Based Diagnostics Market Share by Application (2015-2020)
Table 64. India Key Players Tissue-Based Diagnostics Revenue (2019-2020) (Million US$)
Table 65. India Key Players Tissue-Based Diagnostics Market Share (2019-2020)
Table 66. India Tissue-Based Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 67. India Tissue-Based Diagnostics Market Share by Type (2015-2020)
Table 68. India Tissue-Based Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 69. India Tissue-Based Diagnostics Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Tissue-Based Diagnostics Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Tissue-Based Diagnostics Market Share (2019-2020)
Table 72. Central & South America Tissue-Based Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Tissue-Based Diagnostics Market Share by Type (2015-2020)
Table 74. Central & South America Tissue-Based Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Tissue-Based Diagnostics Market Share by Application (2015-2020)
Table 76. Roche Company Details
Table 77. Roche Business Overview
Table 78. Roche Product
Table 79. Roche Revenue in Tissue-Based Diagnostics Business (2015-2020) (Million US$)
Table 80. Roche Recent Development
Table 81. Danaher Company Details
Table 82. Danaher Business Overview
Table 83. Danaher Product
Table 84. Danaher Revenue in Tissue-Based Diagnostics Business (2015-2020) (Million US$)
Table 85. Danaher Recent Development
Table 86. Thermo Fisher Scientific Company Details
Table 87. Thermo Fisher Scientific Business Overview
Table 88. Thermo Fisher Scientific Product
Table 89. Thermo Fisher Scientific Revenue in Tissue-Based Diagnostics Business (2015-2020) (Million US$)
Table 90. Thermo Fisher Scientific Recent Development
Table 91. Abbott Company Details
Table 92. Abbott Business Overview
Table 93. Abbott Product
Table 94. Abbott Revenue in Tissue-Based Diagnostics Business (2015-2020) (Million US$)
Table 95. Abbott Recent Development
Table 96. Agilent Technologies Company Details
Table 97. Agilent Technologies Business Overview
Table 98. Agilent Technologies Product
Table 99. Agilent Technologies Revenue in Tissue-Based Diagnostics Business (2015-2020) (Million US$)
Table 100. Agilent Technologies Recent Development
Table 101. ABCAM Company Details
Table 102. ABCAM Business Overview
Table 103. ABCAM Product
Table 104. ABCAM Revenue in Tissue-Based Diagnostics Business (2015-2020) (Million US$)
Table 105. ABCAM Recent Development
Table 106. Merck Company Details
Table 107. Merck Business Overview
Table 108. Merck Product
Table 109. Merck Revenue in Tissue-Based Diagnostics Business (2015-2020) (Million US$)
Table 110. Merck Recent Development
Table 111. BD Business Overview
Table 112. BD Product
Table 113. BD Company Details
Table 114. BD Revenue in Tissue-Based Diagnostics Business (2015-2020) (Million US$)
Table 115. BD Recent Development
Table 116. Hologic Company Details
Table 117. Hologic Business Overview
Table 118. Hologic Product
Table 119. Hologic Revenue in Tissue-Based Diagnostics Business (2015-2020) (Million US$)
Table 120. Hologic Recent Development
Table 121. Bio Rad Company Details
Table 122. Bio Rad Business Overview
Table 123. Bio Rad Product
Table 124. Bio Rad Revenue in Tissue-Based Diagnostics Business (2015-2020) (Million US$)
Table 125. Bio Rad Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Tissue-Based Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. Immunohistochemistry (IHC) Features
Figure 3. In Situ Hybridization (ISH) Features
Figure 4. Digital Pathology and Workflow Management Features
Figure 5. Special Staining Features
Figure 6. Global Tissue-Based Diagnostics Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Research Laboratories Case Studies
Figure 9. Pharmaceutical Companies Case Studies
Figure 10. Contract Research Organizations Case Studies
Figure 11. Other Case Studies
Figure 12. Tissue-Based Diagnostics Report Years Considered
Figure 13. Global Tissue-Based Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Tissue-Based Diagnostics Market Share by Regions: 2020 VS 2026
Figure 15. Global Tissue-Based Diagnostics Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Tissue-Based Diagnostics Market Share by Players in 2019
Figure 18. Global Top Tissue-Based Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tissue-Based Diagnostics as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Tissue-Based Diagnostics Revenue in 2019
Figure 20. North America Tissue-Based Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Tissue-Based Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Tissue-Based Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Tissue-Based Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Tissue-Based Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Tissue-Based Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Tissue-Based Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed